Idorsia has a strong and visionary leadership team, with the power and drive to create more remarkable innovations and more new medicines.

Jean-Pierre Garnier

Date of birth: October 31, 1947

Nationality: French and American

Education: MSc in Pharmaceutical Science and PhD in Pharmacology from Louis Pasteur University, Strasbourg, France; MBA from Stanford University, California, US.

Professional background: Various management positions at Schering-Plough. Within SmithKline Beecham, President of the pharmaceutical business in North America (1990), elected to the Board of Directors (1992), Chairman, Pharmaceuticals (from 1994), Chief Operating Officer (COO) (from 1995) and Chief Executive Officer (CEO) (from April 2000). First CEO of GlaxoSmithKline, 2001–2008. CEO of Laboratoires Pierre Fabre, 2008–2010.

Other activities and functions: Member of the Board of Directors of two listed companies, United Technologies Corporation, Radius Health, Inc., and one unlisted company, Alzheon, Inc. (Chairman). Operating Partner of the unlisted company Advent International Corporation. Member of the Advisory Board of Newman’s Own Foundation. Officer of the Legion of Honour and Knight Commander of the Order of the British Empire.

Robert J. Bertolini

Date of birth: December 19, 1961

Nationality: American

Education: BA in Economics from Rutgers, the State University of New Jersey, US; Certified Public Accountant licensed in New York and New Jersey, US.

Professional background: Former Executive Vice President and Chief Financial Officer (CFO) of Schering-Plough Corporation; former President and CFO of Bausch & Lomb, Inc. Various executive positions at PricewaterhouseCoopers; former Member of the Board of Directors of Genzyme Corporation.

Other activities and functions: Member of the Board of Directors of two listed companies, Charles River Laboratories International, Inc., Bristol-Myers Squibb Company, and one unlisted company, Physicians World Speakers Bureau.

Jean-Paul Clozel

Date of birth: April 3, 1955

Nationality: Swiss and French

Education: Medical degree in France; further training in pharmacology and physiology at the University of Montreal, Canada, and the University of California, San Francisco, US.

Professional background: Practicing cardiologist, 1980–1985. Head of Drug Discovery Group in the Cardiovascular Department of F. Hoffmann-La Roche Ltd, 1985–1997. Founder and CEO of Actelion (1999–2017).

Other activities and functions: None.

John J. Greisch

Date of birth: June 10, 1955

Nationality: American

Education: Bachelor’s degree in Business Administration from Miami University, Oxford, Ohio, US; Master’s degree in Management (MBA equivalent) from Northwestern University, Illinois, US.

Professional background: CFO, 2004–2006, and President, International Operations, 2006–2009, at Baxter International, Inc.; President and CEO of Hill-Rom Holdings, Inc., 2010–2018.

Other activities and functions: Member of the Board of two listed companies, Hill-Rom Holdings, Inc., and Catalent, Inc., and one unlisted company, AdvaMed, Advanced Medical Technology Association. Member of the Board of Ann and Robert Lurie Children’s Hospital.

David Stout

Date of birth: June 2, 1954

Nationality: American

Education: BA in Biology.

Professional background: Held various executive and sales and marketing positions with Schering Plough, 1979–1996. Senior Vice President, US Sales and Marketing, SmithKline Beecham, 1996–1998. President, US Pharmaceuticals, 1999–2003, and President, Pharmaceutical Operations, GlaxoSmithKline, 2003–2008.

Other activities and functions: Member of the Board of Directors of one listed company, Jabil, Inc., and two unlisted companies, NanoBio Corporation and Vaxxilon (Chairman).

Herna Verhagen

Date of birth: June 30, 1966

Nationality: Dutch

Education: LLM Business Law, University of Nijmegen (1988); MSc Human Resource Studies, University of Tilburg (1991); International Management, INSEAD (1999); Economics, London School of Economics (2004); MBA, Stanford University (2008).

Professional background: CEO of PostNL N.V. since 2012, having previously served as a member of the Board of Management and held various executive positions within the TNT N.V. Group.

Other activities and functions: Member of the Supervisory Board of one listed company, Rexel S.A. Member of the Executive Committee and General Board of the Confederation of Netherlands Industry and Employers (VNO-NCW), member of the Supervisory Board of the Royal Concertgebouw NV.